Yinghe Technology: Sikary Has No Plan for Nicotine Pouch, Medical or Health Vaporization Products

Business by 2FIRSTS.ai
May.24.2024
Yinghe Technology: Sikary Has No Plan for Nicotine Pouch, Medical or Health Vaporization Products
Investors inquire about Yinghe Technology's subsidiary, Sikary, potential plans to enter European nicotine pouch market, company responds negatively.

On May 23, an investor inquired on an interactive platform about Yinghe Technology (300457): Given the current growth of the nicotine pouch business in Europe, does subsidiary Sikary have plans to introduce nicotine pouch products? If so, in which regions will they be launched?

Yinghe Technology: Sikary Has No Plan for Nicotine Pouch, Medical or Health Vaporization Products
Question and Answer Details | Image Source: Interact Easy

 

In response, Yinghe Technology stated that Sikary currently has no plans to launch a nicotine pouch business.

Yinghe Technology: Sikary Has No Plan for Nicotine Pouch, Medical or Health Vaporization Products
Question and answer details | Image source: Interactive Easy

 

Investors are asking whether the company has plans to develop products in the areas of heated e-cigarettes, oral tobacco products, and cannabis e-cigarettes.

 

In response, Yinghe Technology stated that Sikary is currently not producing cannabis e-cigarettes and has no plans to develop medical or health vaporization products.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.